4th Nov 2020 12:31
Ap19
FORM 8.3
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
1. KEY INFORMATION
| Name of person dealing (Note 1) | Barclays PLC. | |
| Company dealt in | WILLIS TOWERS WATSON PLC | |
| Class of relevant security to which the | ORD | |
| dealings being disclosed relate (Note 2) | ||
| Date of dealing | 03 November 2020 |
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)
| Class of relevant security: | ORD |
|
| ||
Long | Short | ||||
Number | (%) | Number | (%) | ||
(1) | Relevant securities |
|
|
|
|
2,911,968 | 2.26% | 686,362 | 0.53% | ||
|
|
|
| ||
(2) | Derivatives (other than options): |
|
|
|
|
366,484 | 0.28% | 739,005 | 0.57% | ||
|
|
|
| ||
(3) | Options and agreements to |
|
|
|
|
| purchase/sell: | 0 | 0.00% | 0 | 0.00% | |
|
|
|
| ||
| TOTAL: |
|
|
|
| |
3,278,452 | 2.54% | 1,425,367 | 1.11% | ||
|
|
|
| ||
(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)
Class of relevant security: | Long | Short | ||||
| Number |
| (%) | Number |
| (%) |
(1) Relevant securities |
|
| ||||
(2) Derivatives (other than options) |
|
| ||||
(3) Options and agreements to purchase/sell |
|
| ||||
Total |
|
| ||||
| ||||||
Ap20
1. DEALINGS (Note 4)
(a) Purchases and sales
| Purchase/sale | Number of relevant securities | Price per unit |
| Purchase | 1 | 183.9900 USD |
| Purchase | 1 | 183.2400 USD |
| Purchase | 1 | 181.8800 USD |
| Purchase | 1 | 181.5500 USD |
| Purchase | 3 | 183.6433 USD |
| Purchase | 4 | 183.1325 USD |
| Purchase | 12 | 182.6098 USD |
| Purchase | 41 | 181.2400 USD |
| Purchase | 50 | 181.2652 USD |
| Purchase | 100 | 183.5200 USD |
| Purchase | 101 | 181.4305 USD |
| Purchase | 133 | 183.2877 USD |
| Purchase | 627 | 181.9100 USD |
| Purchase | 646 | 181.7728 USD |
| Purchase | 681 | 181.1417 USD |
| Purchase | 902 | 183.5700 USD |
| Purchase | 1,000 | 181.6330 USD |
| Purchase | 1,276 | 183.0913 USD |
| Purchase | 1,897 | 183.3951 USD |
| Purchase | 2,600 | 182.2088 USD |
| Purchase | 3,838 | 181.9731 USD |
| Purchase | 4,508 | 182.2419 USD |
| Purchase | 6,242 | 182.0108 USD |
| Purchase | 7,319 | 182.2122 USD |
| Purchase | 10,000 | 181.7455 USD |
| Purchase | 42,723 | 180.6718 USD |
| Purchase | 453,241 | 180.5100 USD |
| Sale | 4 | 183.3075 USD |
| Sale | 12 | 181.6516 USD |
| Sale | 20 | 182.0230 USD |
| Sale | 100 | 183.6500 USD |
| Sale | 162 | 181.3164 USD |
| Sale | 186 | 181.1927 USD |
| Sale | 194 | 183.0267 USD |
| Sale | 200 | 182.6600 USD |
| Sale | 202 | 181.2793 USD |
| Sale | 217 | 182.1878 USD |
| Sale | 247 | 181.1209 USD |
| Sale | 273 | 183.4108 USD |
| Sale | 300 | 183.9033 USD |
| Sale | 300 | 181.7283 USD |
| Sale | 304 | 182.3488 USD |
| Sale | 411 | 181.8400 USD |
| Sale | 413 | 181.3639 USD |
| Sale | 445 | 181.3053 USD |
| Sale | 567 | 181.0994 USD |
| Sale | 626 | 181.1259 USD |
| Sale | 701 | 181.3275 USD |
| Sale | 902 | 183.5700 USD |
| Sale | 1,200 | 183.0300 USD |
| Sale | 1,400 | 181.7101 USD |
| Sale | 1,636 | 181.6461 USD |
| Sale | 2,207 | 182.6758 USD |
| Sale | 3,444 | 181.7029 USD |
| Sale | 3,712 | 182.1259 USD |
| Sale | 3,994 | 180.5144 USD |
| Sale | 4,355 | 182.2920 USD |
| Sale | 6,609 | 182.2584 USD |
| Sale | 10,167 | 181.9171 USD |
| Sale | 15,500 | 180.5247 USD |
| Sale | 28,596 | 180.8136 USD |
| Sale | 448,214 | 180.5100 USD |
(b) Derivatives transactions (other than options transactions)
Product name, e.g. CFD | Nature of transaction (Note 6) | Number of relevant securities (Note 7) | Price per unit (Note 5) |
|
|
|
|
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
Product name, e.g. call option | Writing, selling, purchasing, varying etc. | Number of securities to which the option relates (Note 7) | Exercise price | Type, e.g. American, European etc. | Expiry date | Option money paid/received per unit (Note 5) |
|
|
|
|
|
|
|
(ii) Exercising
Product name, e.g. call option | Number of securities | Exercise price per unit (Note 5) |
|
|
|
(d) Other dealings (including transactions in respect of new securities) (Note 4)
Nature of transaction (Note 8) | Details | Price per unit (if applicable) (Note 5) |
|
|
|
Ap21
2. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.
None
| Is a Supplemental Form 8 (Open Positions) attached? | NO |
| Date of disclosure: | 4 Nov 2020 |
| Contact name: | Large Holdings Regulatory Operations |
| Telephone number: | 020 3134 7213 |
| If a connected EFM, name of offeree/offeror with which connected | |
| If a connected EFM, state nature of connection |
View source version on businesswire.com: https://www.businesswire.com/news/home/20201104005315/en/
Copyright Business Wire 2020
Related Shares:
Barclays